Drug Shortage Report for TARO-PREGABALIN

Last updated on 2021-07-13 History
Report ID 141040
Drug Identification Number 02392860
Brand name TARO-PREGABALIN
Common or Proper name PREGABALIN
Company Name SUN PHARMA CANADA INC
Market Status MARKETED
Active Ingredient(s) PREGABALIN
Strength(s) 300MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-06-01
Estimated end date 2021-07-16
Actual end date 2021-06-30
Shortage status Resolved
Updated date 2021-07-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-07-13 French Compare
v3 2021-07-13 English Compare
v2 2021-06-16 French Compare
v1 2021-06-16 English Compare

Showing 1 to 4 of 4